Cytopathology — MCQs

A 58-year-old man presents with severe back pain. His history is negative for trauma and he has no other complaints. He denies urinary frequency, hesitancy, or dysuria. A digital rectal examination confirms the presence of a firm, hard, asymmetrical, and stony prostate, suggestive of prostatic malignancy. In addition to PSA, which of the following markers can be demonstrated in the tumor cells?

Q67Easy

Which stain is used for Pneumocystis carinii?

Q68Easy

According to the Betheseda criteria for solitary thyroid nodules, which category is classified as a 'follicular neoplasm'?

Q69Medium

A patient presents with respiratory symptoms including cough, hemoptysis, and glomerulonephritis. The c-ANCA level in serum was found to be elevated. What is the most likely diagnosis?

Q70Medium

A 44-year-old woman presents with increasing abdominal distention over the past 6 weeks. Physical examination reveals an abdominal fluid wave and present bowel sounds. Paracentesis yields 1000 mL of slightly cloudy serous fluid containing malignant cells consistent with adenocarcinoma. Molecular analysis of these cells shows an MSH2 gene mutation with microsatellite instability. Her medical history is otherwise unremarkable. Her sister was diagnosed with endometrial cancer, and her brother had gastric carcinoma. What is the most likely diagnosis explaining this patient's symptoms?

Cytopathology Indian Medical PG Practice Questions and MCQs

Question 61: Urinary cytology is a useful screening test for the diagnosis of which of the following conditions?

A. Renal cell carcinoma
B. Wilm's tumour
C. Urothelial carcinoma (Correct Answer)
D. Carcinoma prostate

Explanation: **Explanation:** **Urothelial carcinoma (Option C)** is the correct answer because urinary cytology relies on the principle of **exfoliation**. Urothelial cells (transitional epithelium) line the entire urinary tract from the renal pelvis to the proximal urethra. Malignant urothelial cells have decreased intercellular cohesion, causing them to shed easily into the urine stream [1]. This makes voided urine or bladder washings a highly specific, non-invasive screening and follow-up tool for detecting high-grade urothelial carcinomas and Carcinoma in Situ (CIS). **Why other options are incorrect:** * **Renal cell carcinoma (Option A):** These tumors arise from the renal tubular epithelium. They rarely communicate with the collecting system until they are very large or advanced; therefore, malignant cells are seldom found in urine. * **Wilm’s tumour (Option B):** This is a pediatric renal tumor (nephroblastoma) that is typically encapsulated. It does not exfoliate cells into the urinary tract, making cytology ineffective for diagnosis. * **Carcinoma prostate (Option C):** While the prostate is anatomically related, prostatic adenocarcinoma cells do not routinely exfoliate into the urine. Diagnosis is primarily via Serum PSA and TRUS-guided biopsy. **High-Yield Clinical Pearls for NEET-PG:** * **Sensitivity vs. Specificity:** Urinary cytology has **high specificity (>90%)** but low sensitivity for low-grade tumors (where cells look nearly normal). * **The Paris System:** This is the standard international reporting system used for urinary cytology. * **Key Cytological Feature:** Look for a high N:C ratio, hyperchromasia, and irregular nuclear membranes (malignant features). * **Best Sample:** A fresh morning sample (but not the first voided urine, as cells may be degenerated) is preferred. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 970-971.

Question 62: Which of the following is the earliest manifestation of Crohn disease?

A. Stricture
B. Aphthous ulcer (Correct Answer)
C. Cobblestone appearance
D. Perforation

Explanation: **Explanation:** The earliest macroscopic manifestation of **Crohn Disease (CD)** is the **aphthous ulcer** [3]. These are small, shallow, punched-out ulcers that develop over lymphoid follicles (Peyer’s patches) in the intestinal mucosa. As the disease progresses, these ulcers enlarge, become longitudinal and serpiginous, and eventually coalesce to create the characteristic "cobblestone" appearance [3]. **Analysis of Options:** * **Aphthous Ulcer (Correct):** These represent the initial stage of mucosal injury. They are often surrounded by a halo of erythema and are the precursor to deeper ulcerations. * **Cobblestone Appearance:** This is a **late/established feature** of CD. It results from the intersection of deep longitudinal ulcers with islands of residual, edematous, and normal-appearing mucosa [3]. * **Stricture:** This is a **chronic complication** caused by transmural inflammation and subsequent fibrosis [1]. It leads to the "string sign of Kantor" on imaging and can cause intestinal obstruction [3]. * **Perforation:** This is a **severe, late-stage complication**. While CD is characterized by transmural inflammation, the intense fibrotic response often prevents free perforation; instead, it more commonly leads to fistula or abscess formation [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Hallmark:** Transmural inflammation with **non-caseating granulomas** (seen in ~35% of cases) [2]. * **Distribution:** "Skip lesions" (segmental involvement); most common site is the **terminal ileum** [1]. * **Creeping Fat:** Mesenteric fat extends around the serosal surface of the bowel, a classic surgical finding in CD. * **Microscopy:** Look for "knife-like" fissures and lymphoid aggregates [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 365-366. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 806-807. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 366-367.

Question 63: Which of the following diseases is not a cause of indirect hyperbilirubinemia?

A. Rotor syndrome (Correct Answer)
B. Crigler-Najjar syndrome
C. Gilbert syndrome
D. Hereditary spherocytosis

Explanation: To understand this question, one must distinguish between pre-microsomal (unconjugated/indirect) and post-microsomal (conjugated/direct) hyperbilirubinemia. ### **Explanation of the Correct Answer** **A. Rotor Syndrome:** This is an autosomal recessive condition characterized by a defect in the **hepatic storage and excretion** of bilirubin into the bile canaliculi [1]. Since the bilirubin has already been processed by the enzyme UDP-glucuronosyltransferase (UGT) in the liver, it is **conjugated (direct)**. Therefore, Rotor syndrome causes direct hyperbilirubinemia, making it the correct answer. ### **Why the Other Options are Incorrect** * **B & C. Crigler-Najjar and Gilbert Syndromes:** Both are caused by deficiencies in the **UGT1A1 enzyme** [1]. Gilbert syndrome involves a mild decrease in enzyme activity, while Crigler-Najjar involves a severe or total absence. Because the liver cannot conjugate the bilirubin, it remains **unconjugated (indirect)**. * **D. Hereditary Spherocytosis:** This is a hemolytic anemia. Excessive breakdown of red blood cells overwhelms the liver's conjugating capacity, leading to an accumulation of **unconjugated (indirect)** bilirubin [2]. ### **High-Yield Clinical Pearls for NEET-PG** * **Direct Hyperbilirubinemia (Conjugated):** Think **Dubin-Johnson** (Black liver due to pigment) and **Rotor Syndrome** (Normal liver color) [1]. * **Indirect Hyperbilirubinemia (Unconjugated):** Think **Gilbert**, **Kirgler-Najjar**, and **Hemolysis** [1], [2]. * **The "Black Liver" Rule:** Dubin-Johnson syndrome shows a dark-pigmented liver on biopsy due to impaired excretion of epinephrine metabolites; Rotor syndrome does NOT show this pigmentation [1]. * **Urine Findings:** Conjugated bilirubin is water-soluble and appears in urine (dark urine), whereas unconjugated bilirubin is lipid-soluble and bound to albumin, so it cannot pass into the urine [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 860. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 640. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 380-385.

Question 64: Which stain is used to highlight mucin?

A. PAS
B. Alcian blue (Correct Answer)
C. Oil red O
D. Sudan black

Explanation: **Explanation:** **Alcian Blue** is the stain of choice for highlighting **acidic mucins** (acid mucopolysaccharides). In cytopathology and histopathology, it stains these substances a striking bright blue. It is frequently used to identify goblet cells in Barrett’s esophagus [1] or to detect mucin-secreting adenocarcinomas. **Analysis of Options:** * **PAS (Periodic Acid-Schiff):** While PAS stains neutral mucins, glycogen, and basement membranes magenta, it is not the specific answer when "mucin" is asked generally in a competitive context, as Alcian Blue is more specific for acidic mucosubstances. Often, a **PAS-Alcian Blue** combination is used to differentiate between neutral and acidic mucins. * **Oil Red O:** This is a specialized stain used to identify **neutral lipids and triglycerides**. It requires frozen sections because routine processing (xylol) dissolves fat. * **Sudan Black B:** This is primarily used to stain **lipids and phospholipids**. In hematopathology, it is a high-yield stain for identifying myeloblasts (granulocyte precursors) to differentiate AML from ALL. **High-Yield Clinical Pearls for NEET-PG:** * **Mucicarmine (Mayer’s):** Another specific stain for mucin (stains it red). It is the gold standard for identifying *Cryptococcus neoformans* (capsule) and certain adenocarcinomas. * **Best’s Carmine:** Specifically used for Glycogen. * **Prussian Blue (Perl’s):** Used for Iron (Hemosiderin). * **Masson’s Trichrome:** Used to differentiate collagen (blue/green) from muscle (red). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349.

Question 65: Which of the following tests is unable to differentiate between in situ breast cancer and invasive disease?

A. Core needle biopsy
B. Fine needle aspiration cytology (FNAC) (Correct Answer)
C. Excisional biopsy
D. None of the above

Explanation: The fundamental distinction between **In Situ Carcinoma** (e.g., DCIS) and **Invasive Carcinoma** is the integrity of the **basement membrane** [1]. **Why FNAC is the correct answer:** Fine Needle Aspiration Cytology (FNAC) involves the aspiration of individual cells or small clusters using a thin needle. While FNAC can identify malignant features (nuclear pleomorphism, high N:C ratio), it provides **cytological detail only**. It cannot preserve the architectural relationship between the tumor cells and the surrounding stroma [3]. Because it cannot visualize whether the basement membrane has been breached, FNAC is unable to differentiate between in situ and invasive disease. **Analysis of other options:** * **Core Needle Biopsy (CNB):** Unlike FNAC, CNB provides a **tissue core (histology)**. This allows the pathologist to see the architecture and confirm if tumor cells have invaded the stroma. It is currently the gold standard for preoperative diagnosis. * **Excisional Biopsy:** This involves the removal of the entire lump [1]. It provides the most definitive histological assessment of the tumor-stroma interface and the basement membrane. **High-Yield Clinical Pearls for NEET-PG:** * **Limitation of FNAC:** It cannot distinguish between Ductual Carcinoma In Situ (DCIS) and Invasive Ductal Carcinoma (IDC). * **Myoepithelial Layer:** The presence of a myoepithelial cell layer (confirmed by IHC markers like **p63, SMA, or Calponin**) signifies in situ disease; its loss indicates invasive cancer [2]. * **Triple Assessment:** The standard protocol for breast lumps includes Clinical Examination, Imaging (Mammography/USG), and Pathology (preferably Core Biopsy). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 209-210. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1060-1061. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1061-1062.

Question 66: A 58-year-old man presents with severe back pain. His history is negative for trauma and he has no other complaints. He denies urinary frequency, hesitancy, or dysuria. A digital rectal examination confirms the presence of a firm, hard, asymmetrical, and stony prostate, suggestive of prostatic malignancy. In addition to PSA, which of the following markers can be demonstrated in the tumor cells?

A. AMACR (Correct Answer)
B. AFP
C. Podoplanin
D. OCT-3/4

Explanation: **Explanation:** The clinical presentation of a 58-year-old male with a stony-hard prostate and back pain (suggestive of bone metastasis) strongly points toward **Prostate Adenocarcinoma** [1]. While Prostate-Specific Antigen (PSA) is the most common serum marker, immunohistochemistry (IHC) is essential for tissue diagnosis. **Why AMACR is correct:** **AMACR (Alpha-Methylacyl-CoA Racemase)**, also known as **P504S**, is a highly sensitive and specific positive marker for prostatic adenocarcinoma [1]. It is significantly upregulated in malignant prostatic epithelium compared to benign tissue. In diagnostic pathology, it is often used in a "Triple Stain" cocktail along with basal cell markers (like p63 or High Molecular Weight Cytokeratin). Since prostate cancer is characterized by the **absence of a basal cell layer**, a positive AMACR stain combined with a negative p63 stain confirms malignancy [1]. **Why other options are incorrect:** * **AFP (Alpha-Fetoprotein):** A marker for Yolk Sac Tumors and Hepatocellular Carcinoma (HCC). * **Podoplanin (D2-40):** A marker for lymphatic endothelium, used to identify lymphatic invasion or tumors like Mesothelioma and Seminoma. * **OCT-3/4:** A transcription factor used as a marker for pluripotency, typically positive in Germ Cell Tumors (especially Seminoma and Embryonal Carcinoma). **NEET-PG High-Yield Pearls:** * **Most common site:** Peripheral zone (hence detectable via Digital Rectal Examination) [3]. * **Gleason Scoring:** Based on glandular differentiation (Pattern 1-5); it is the most important prognostic factor [1]. * **Osteoblastic Metastasis:** Prostate cancer characteristically causes "bone-forming" (sclerotic) lesions, often involving the lumbar spine via the Batson venous plexus [2]. * **IHC Profile:** Prostate Cancer = AMACR (+), p63 (-), HMWCK (-). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 990-992. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 501-502. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 989-990.

Question 67: Which stain is used for Pneumocystis carinii?

A. Methylene blue
B. Gram stain
C. Hematoxylin and eosin
D. Methenamine silver (Correct Answer)

Explanation: **Explanation:** **Pneumocystis jirovecii** (formerly *P. carinii*) is a yeast-like fungus that is a significant cause of opportunistic pneumonia in immunocompromised patients, particularly those with HIV/AIDS. **Why Option D is Correct:** **Gomori Methenamine Silver (GMS)** is the gold standard stain for identifying *Pneumocystis*. It specifically stains the **cyst wall** of the organism black or dark brown against a pale green background. Under a microscope, these cysts typically appear as crushed ping-pong balls or crescent-shaped structures, often showing a characteristic "bracket-like" or "comma-shaped" focal thickening in the wall. **Why Other Options are Incorrect:** * **A. Methylene blue:** While it can stain some fungal elements, it lacks the specificity and contrast required to reliably identify the delicate cyst walls of *Pneumocystis*. * **B. Gram stain:** *Pneumocystis* does not take up Gram stain effectively. It is primarily used for identifying bacteria based on peptidoglycan content in cell walls. * **C. Hematoxylin and Eosin (H&E):** On H&E, *Pneumocystis* appears only as an amorphous, eosinophilic, "foamy" or "honeycomb" intra-alveolar exudate. The individual cysts themselves are usually invisible or poorly defined, necessitating special stains for confirmation. **High-Yield Clinical Pearls for NEET-PG:** * **Alternative Stain:** **Toluidine Blue O** also stains the cyst walls, while **Giemsa/Wright stain** is used to visualize the **trophozoites** (nuclei) but not the cyst wall. * **Specimen of Choice:** Bronchoalveolar Lavage (BAL) is more sensitive than induced sputum for diagnosis. * **Radiology:** Classically presents with bilateral perihilar "ground-glass opacities" on X-ray/CT. * **Treatment:** Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice for both treatment and prophylaxis.

Question 68: According to the Betheseda criteria for solitary thyroid nodules, which category is classified as a 'follicular neoplasm'?

A. TIRADS 1c
B. TIRADS 2
C. TIRADS 3
D. TIRADS 4 (Correct Answer)

Explanation: The **Bethesda System for Reporting Thyroid Cytopathology (BSRTC)** is the gold standard for classifying Fine Needle Aspiration (FNA) results of thyroid nodules. It uses a 6-tier system to estimate malignancy risk and guide clinical management. **Correct Option: D (TIRADS 4)** In the Bethesda classification, **Category IV** is specifically designated as **"Follicular Neoplasm"** or "Suspicious for a Follicular Neoplasm." This category is used when the aspirate shows high cellularity and a monotonous population of follicular cells (often in microfollicular patterns) with an absence of colloid [1]. It is a "gray zone" because cytology cannot distinguish between a benign follicular adenoma and a malignant follicular carcinoma; the latter requires histological evidence of capsular or vascular invasion [2]. **Explanation of Incorrect Options:** * **TIRADS 1 (Non-diagnostic/Unsatisfactory):** This indicates an inadequate sample (e.g., only blood, cyst fluid, or too few follicular cells). * **TIRADS 2 (Benign):** This is the most common result, representing colloid nodules or Hashimoto’s thyroiditis [4]. The risk of malignancy is <3%. * **TIRADS 3 (Atypia of Undetermined Significance / Follicular Lesion of Undetermined Significance - AUS/FLUS):** This category is used when cells show architectural or nuclear atypia that is not sufficient to be called a neoplasm. **High-Yield Clinical Pearls for NEET-PG:** * **Malignancy Risk:** Category IV carries a **10–40%** risk of malignancy. * **Management:** The standard recommendation for Category IV is **surgical lobectomy** (diagnostic thyroidectomy) because FNA cannot confirm invasion [2]. * **Hurthle Cell Neoplasm:** This is a variant of Category IV characterized by an abundance of mitochondria-rich oxyphilic cells [2]. * **Bethesda VI:** Represents "Malignant" (97–99% risk), most commonly Papillary Thyroid Carcinoma (PTC) showing Orphan Annie eye nuclei and Psammoma bodies [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1096-1097. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-430. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1095-1096.

Question 69: A patient presents with respiratory symptoms including cough, hemoptysis, and glomerulonephritis. The c-ANCA level in serum was found to be elevated. What is the most likely diagnosis?

A. Goodpasture's syndrome
B. Classic polyarteritis nodosa
C. Wegener's granulomatosis (Correct Answer)
D. Kawasaki syndrome

Explanation: ### Explanation The correct diagnosis is **Wegener’s Granulomatosis** (now commonly referred to as Granulomatosis with Polyangiitis or GPA). **Why Option C is Correct:** Wegener’s granulomatosis is characterized by a classic clinical triad [1]: 1. **Necrotizing granulomas** of the upper and lower respiratory tract (causing cough and hemoptysis). 2. **Necrotizing vasculitis** of small to medium-sized vessels. 3. **Renal disease** (typically focal necrotizing glomerulonephritis). The most specific laboratory marker for this condition is the presence of **c-ANCA** (cytoplasmic Antineutrophil Cytoplasmic Antibodies), which target **Proteinase-3 (PR3)** [1]. The combination of respiratory symptoms, renal involvement, and elevated c-ANCA is pathognomonic for GPA [4]. **Why Other Options are Incorrect:** * **A. Goodpasture’s Syndrome:** While it also presents with a pulmonary-renal syndrome (hemoptysis and glomerulonephritis), it is caused by **anti-GBM antibodies** (Type II hypersensitivity) and is **not** associated with c-ANCA [3]. * **B. Classic Polyarteritis Nodosa (PAN):** This involves medium-sized arteries and commonly affects the skin, gut, and kidneys (renal artery), but it characteristically **spares the lungs** and is usually ANCA-negative [5]. * **D. Kawasaki Syndrome:** This is a pediatric vasculitis affecting medium-sized vessels (notably coronary arteries). It presents with "strawberry tongue," fever, and conjunctivitis, rather than pulmonary-renal symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **c-ANCA (PR3-ANCA):** Highly specific for Wegener’s Granulomatosis [1]. * **p-ANCA (MPO-ANCA):** Associated with Microscopic Polyangiitis (MPA) and Churg-Strauss Syndrome [5]. * **Histopathology:** Look for "geographic necrosis" and "crescentic glomerulonephritis" (RPGN Type III/Pauci-immune) [2]. * **Treatment:** Cyclophosphamide and corticosteroids are the mainstays of therapy [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 519-520. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 917-918. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 322-323. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 536-537. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 518-519.

Question 70: A 44-year-old woman presents with increasing abdominal distention over the past 6 weeks. Physical examination reveals an abdominal fluid wave and present bowel sounds. Paracentesis yields 1000 mL of slightly cloudy serous fluid containing malignant cells consistent with adenocarcinoma. Molecular analysis of these cells shows an MSH2 gene mutation with microsatellite instability. Her medical history is otherwise unremarkable. Her sister was diagnosed with endometrial cancer, and her brother had gastric carcinoma. What is the most likely diagnosis explaining this patient's symptoms?

A. Angiodysplasia
B. Crohn disease
C. Diverticulosis
D. Lynch syndrome (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Lynch Syndrome** The patient presents with malignant ascites (adenocarcinoma) and a significant family history of extra-colonic cancers (endometrial and gastric). The definitive clue is the molecular finding of an **MSH2 gene mutation** and **microsatellite instability (MSI)**. Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer - HNPCC) is an autosomal dominant condition caused by germline mutations in **DNA mismatch repair (MMR) genes** (most commonly *MLH1, MSH2, MSH6,* and *PMS2*). Failure of MMR leads to the accumulation of errors in repetitive DNA sequences, known as microsatellite instability [1]. While colorectal cancer is the most common manifestation, patients are at high risk for **extracolonic malignancies**, particularly endometrial (most common in women), ovarian, gastric, and small bowel carcinomas [1]. In this case, the malignant ascites likely originated from a primary ovarian or colorectal carcinoma [2]. **Why Incorrect Options are Wrong:** * **A, B, & C:** Angiodysplasia, Crohn disease, and Diverticulosis are all benign conditions. While they can cause abdominal symptoms or GI bleeding, they do not involve MSH2 mutations, microsatellite instability, or the production of malignant serous effusions. **Clinical Pearls for NEET-PG:** * **Amsterdam II Criteria (3-2-1 Rule):** 3 relatives with Lynch-associated cancer, 2 successive generations, 1 diagnosed before age 50. * **Most common MMR mutation:** *MLH1* and *MSH2*. * **Most common extracolonic site:** Endometrium [1]. * **Pathology:** Lynch-associated colorectal cancers are often right-sided (proximal to splenic flexure) and may show "medullary" histology with prominent tumor-infiltrating lymphocytes [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 817. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 819-821.

Practice by Chapter

Basic Principles of Cytopathology

Practice Questions

Specimen Collection and Processing

Practice Questions

Gynecologic Cytology

Practice Questions

Respiratory Tract Cytology

Practice Questions

Urinary Tract Cytology

Practice Questions

Effusion Cytology

Practice Questions

Fine Needle Aspiration Cytology

Practice Questions

Gastrointestinal Tract Cytology

Practice Questions

Ancillary Studies in Cytopathology

Practice Questions

Quality Assurance in Cytopathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free